| |
| |
|
| Insider
Information: |
Kwon Young |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
301,441 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,743,113 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
301,441 |
|
|
| Total
Value |
$2,743,113 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 74.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Chief Financial & Bus.... |
2020-10-01 |
0 |
2018-04-19 |
0 |
Premium* |
|
|
ADMA Biologics Inc |
ADMA |
|
2024-02-26 |
301,441 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMA |
ADMA Biologics Inc |
|
– • – |
2021-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
% |
|
| ADMA |
ADMA Biologics Inc |
|
• • – |
2021-10-25 |
4 |
B |
$1.00 |
$100,000 |
D/D |
100,000 |
200,000 |
0.01 |
% |
|
| ADMA |
ADMA Biologics Inc |
|
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,586 |
226,586 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
|
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,815 |
252,401 |
0 |
- |
|
| ADMA |
ADMA Biologics Inc |
|
• • – |
2023-08-24 |
4 |
B |
$3.90 |
$97,500 |
D/D |
25,000 |
277,401 |
0.01 |
% |
|
| ADMA |
ADMA Biologics Inc |
|
• • – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,040 |
301,441 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-04-19 |
4 |
AS |
$20.90 |
$315,360 |
D/D |
(15,089) |
141,911 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-04-19 |
4 |
OE |
$12.58 |
$212,838 |
D/D |
14,589 |
144,411 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-08 |
4 |
AS |
$18.08 |
$8,913 |
D/D |
(493) |
142,827 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,409 |
143,320 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-09 |
4 |
OE |
$12.58 |
$202,260 |
D/D |
14,000 |
144,827 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-09 |
4 |
AS |
$21.90 |
$317,550 |
D/D |
(14,500) |
142,327 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-10 |
4 |
AS |
$21.95 |
$7,726 |
D/D |
(352) |
141,975 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-17 |
4 |
AS |
$22.90 |
$343,500 |
D/D |
(15,000) |
140,975 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-17 |
4 |
OE |
$12.58 |
$202,260 |
D/D |
14,000 |
143,975 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-21 |
4 |
AS |
$23.40 |
$8,213 |
D/D |
(351) |
140,624 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-23 |
4 |
AS |
$23.90 |
$418,250 |
D/D |
(17,500) |
137,624 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-23 |
4 |
OE |
$12.58 |
$208,890 |
D/D |
14,500 |
142,624 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-06-05 |
4 |
AS |
$24.90 |
$25 |
D/D |
(1) |
137,623 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-07-12 |
4 |
AS |
$25.40 |
$1,183,025 |
D/D |
(46,499) |
125,624 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-07-12 |
4 |
OE |
$12.58 |
$509,220 |
D/D |
34,500 |
139,623 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-07-13 |
4 |
OE |
$12.58 |
$584,430 |
D/D |
38,500 |
129,624 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-07-13 |
4 |
AS |
$27.33 |
$1,355,985 |
D/D |
(49,500) |
114,624 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-07-18 |
4 |
AS |
$28.90 |
$1,031,356 |
D/D |
(35,164) |
111,624 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-07-18 |
4 |
OE |
$13.02 |
$520,695 |
D/D |
32,164 |
118,624 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
